Skip to main content
Erschienen in: BMC Cancer 1/2012

Open Access 01.12.2012 | Research article

Measuring the quality of MDT working: an observational approach

verfasst von: Cath Taylor, Louise Atkins, Alison Richardson, Ruth Tarrant, Amanda-Jane Ramirez

Erschienen in: BMC Cancer | Ausgabe 1/2012

Abstract

Background

Cancer multidisciplinary teams (MDTs) are established in many countries but little is known about how well they function. A core activity is regular MDT meetings (MDMs) where treatment recommendations are agreed. A mixed methods descriptive study was conducted to develop and test quality criteria for observational assessment of MDM performance calibrated against consensus from over 2000 MDT members about the “characteristics of an effective MDT”.

Methods

Eighteen of the 86 ‘Characteristics of Effective MDTs’ were considered relevant and feasible to observe. They collated to 15 aspects of MDT working covering four domains: the team (e.g. attendance, chairing, teamworking); infrastructure for meetings (venue, equipment); meeting organisation and logistics; and patient-centred clinical decision-making (patient-centredness, clarity of recommendations). Criteria for rating each characteristic from ‘very poor’ to ‘very good’ were derived from literature review, observing MDMs and expert input. Criteria were applied to 10 bowel cancer MDTs to assess acceptability and measure variation between and within teams. Feasibility and inter-rater reliability was assessed by comparing three observers.

Results

Observational assessment was acceptable to teams and feasible to implement. Total scores from 29 to 50 (out of 58) highlighted wide diversity in quality between teams. Eight teams were rated either ‘very good/good’ or ‘very poor/poor’ for at least three domains demonstrating some internal consistency. ‘Very good’ ratings were most likely for attendance and administrative preparation, and least likely for patient-centredness of decision-making and prioritisation of complex cases. All except two characteristics had intra-class correlations of ≥0.50.

Conclusions

This observational tool (MDT-OARS) may contribute to the assessment of MDT performance. Further testing to confirm validity and reliability is required.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2407-12-202) contains supplementary material, which is available to authorized users.

Competing interest

The authors declare they have no competing interests.

Authors' contributions

All named authors have agreed to the submission of this manuscript and participated in this study to a sufficient extent to be named as authors. AJR, AR and CT conceived the idea for the study; CT was the study lead and wrote the first draft of the paper. All authors participated in the development and/or application of the quality criteria, the critical revision of the article and have read and approved the final manuscript.

Background

Cancer multidisciplinary teams (MDTs) are well established in the UK and other countries as a core mechanism for improving patient outcomes. A core activity is regular MDT meetings (MDMs), held weekly for most tumour types, which brings together all relevant health professionals to discuss and agree patient treatment plans.
The benefits of MDTs in relation to improved adherence to evidence-based guidelines, better treatment decisions, and association with better clinical outcomes including survival have been well documented [1, 2]. Nevertheless MDTs are a very expensive resource and we know little about how well they individually function. The UK national annual cancer peer review programme provides a mandatory mechanism for assessment of MDTs. MDTs have to show their compliance with standards that are derived from tumour-specific improving outcomes guidance (which is in turn based on evidence and/or clinical consensus). Data from the peer-review programme demonstrates wide variation between teams in adherence to standards [3, 4]. The standards encompass structural features of MDTs such as team composition (having the required expertise) and having protocols for referral and treatment but omit other aspects of MDT functioning such as the quality of leadership and chairing; teamwork (e.g. inclusiveness and mutual respect); and the clinical decision-making process.
Evidence is accruing regarding the association between process and outcomes in cancer MDTs [2]. The quality of diagnostic and treatment decisions has been related to MDT discussion in a range of tumour types [57]. The quality of MDT recommendations relies upon considera-tion of all relevant information. Failure to consider patient-based information has been shown to be a major reason for non-implementation of recommendations, either due to being unacceptable to patients or clinically inappropriate [811]. Moreover, non-implementation of MDT meeting recommendations can have both clinical and financial consequences if further discussion is required and treatment is delayed. This is likely to require inclusive discussions in MDT meetings but research has shown that cancer MDT meetings may prioritise the medical model and place less value on the contributions of non-medical members of the team [12, 13].
Robust assessment of the complex behaviours and activi-ties in MDMs is likely to require mixed methods including independent observation [14, 15]. Observational measures have been developed to assess teamwork in other healthcare teams, such as surgical teams [16, 17]. To apply such methods to MDTs first requires agreement about the optimal MDT characteristics. Determining causal relationships between teamworking and outcome is riddled with methodological challenges, which may partly account for the lack of empirical research regarding predictors of effectiveness [1]. Nevertheless, consensus of opinion in a recent UK national survey completed by over 2000 MDT members [18] resulted in recommendations for MDT working: ‘The characteristics of an effective MDT’ [19]. Eighty-six ‘characteristics of effectiveness’ are organised within five domains: The Team; Infrastructure for meetings; Meeting organisation and logistics; Clinical decision-making; and Clinical governance. These characteristics provide a framework against which to develop objective criteria for assessing the quality of teamworking in MDMs.

Aims

  • • To develop quality criteria for assessment of characteristics observable in MDMs
  • • To conduct preliminary tests of their acceptability with 10 bowel cancer teams, to include describing:
    • ∘ the variation within and between teams
    • ∘ the characteristics most/least likely to receive high quality ratings
  • • To test inter-rater reliability and feasibility

Methods

Development of MDT-OARS (Observational Assessment Rating Scale)

Each of the 86 ‘characteristics of effective MDTs’ [19] was considered in turn for its relevance and feasibility for independent observational measurement in MDT meetings. Additional consideration was given to whether the characteristics were already measured in national peer review assessments, and priority was given to including characteristics that did not overlap with peer review. In total 18 of the 86 characteristics were felt to be observable. Due to overlap between characteristics these aggregated into 15 aspects of teamworking (Table 1).
Table 1
MDT-OARS quality criteria and shortened manual for rating each of 15 observable characteristics of effective teamworking in MDT meetings
Characteristic of effective MDT working
Quality Criteria
Quality of team working (score in brackets)
Very Poor
Poor
Good
Very Good
The Team
  
Attendance
Presence of relevant core team members at the meeting
at least one core team member (and their deputy) is not present for the whole meeting
at least one core team member (and deputy) is absent for most of the meeting (≥3 cases)
at least one core team member (and deputy) is absent for part of the meeting (≤ 2 cases)
all core team members (or deputy) present for whole meeting
  
(1)
(2)
(3)
(4)
Leadership: chairing of meeting
· Keeps meeting to agenda (i.e. moves onto next case)
Satisfies none of criteria
Only satisfies 1–2 of criteria
Satisfies 3 of criteria
Evidence of all of the criteria
 
· Encourages overall participation
    
 
· Encourages focussed discussion
    
 
· Articulates recommendation
(1)
(2)
(3)
(4)
Teamworking & culture
a) Inclusion of relevant team members
· All relevant core members are actively and appropriately involved
Satisfies 1/none of criteria
Satisfies 2–4 of criteria
Satisfies “all relevant core members are actively and appropriately involved” and at least 3 other criteria
Satisfies all of the criteria
 
· Meeting not dominated by 1-2 people
    
 
· Input/questions volunteered and encouraged
    
 
· Contributions facilitate decision-making and/or inform discussion
    
 
· Consensus of decision-making
(1)
(2)
(3)
(4)
b) Team Sociability
· Evidence of humour
Satisfies none of the criteria
Satisfies 1 of criteria
Satisfies 2–3 of criteria
Satisfies all of criteria
 
· Team appear relaxed with each other
    
 
· Warm and supportive team environment
    
 
· Friendly and cooperative communicative style
(1)
(2)
(3)
(4)
c) Mutual respect
· Focussed attention
Only satisfies 1 or none of
Satisfies 2–3 of criteria
Evidence of respect,
Strong evidence of
 
· Respect for speaker
criteria
 
evidence of at least 4
respect in all/almost all
 
· No concurrent discussions
  
criteria
cases
 
· Asking and valuing relevant contributions
    
 
· General sense of politeness/courtesy (inc mobile phone etiquette)
(1)
(2)
(3)
(4)
d) tension and conflict
 
Not rated on the same scale – see bottom of table
Personal development & training
Observable communication of research evidence and/or instances of learning
No observable communication of research evidence or instances of learning
Minimal communication of research evidence or instances of learning
Structured presentation of research evidence and/or learning through formal discussion (e.g. of audit findings
  
(1)
(2)
(3)
Infrastructure for meetings
  
Meeting venue
· Room size appropriate for number of team members
Satisfies only 1 or none of criteria
Satisfies 2 of the criteria
Satisfies 3 of the criteria
Satisfies all of the criteria
 
· Layout of chairs enables accessible viewing of diagnostics
    
 
· Layout of room allows accessible viewing of other team members
    
 
· All members seated on a chair
    
 
· Suitable venue in terms of location, temperature, lighting etc
(1)
(2)
(3)
(4)
Technology & equipment
Availability of diagnostic equipment to view and share images and pathology with the team.
No radiology imaging facilities
Light box available with hard copy film
Current images available digitally with facilities for projecting/viewing images
Current images available digitally with facilities for projecting/viewing images and capability of accessing retrospective images (e.g. use of PACS)
 
Availability of multiple screens scores extra 1 point. Score out of possible 9 is then standardised onto 1-4 scale to give overall rating.
     
  
(1)
(2)
(3)
(4)
  
No histopathology facilities
Microscope
Microscope with facilities for projecting/viewing specimen/biopsy
Microscope with facilities for projecting and viewing specimen/biopsy and accessing retrospective data
  
(1)
(2)
(3)
(4)
Meeting organisation and logistics
      
Preparation prior to meetings:
      
a) agenda
Availability and content of agenda
No available agenda
Agenda, but limited info
Comprehensive agenda
  
(1)
(2)
(3)
b) prioritisation of complex cases
Prioritisation of complex cases on agenda to enable sufficient time for their discussion
No attempt is made to order cases in terms of complexity and an inappropriate amount of time is spent on cases (i.e. too much or too little)
Some attempt is made to order cases in terms of complexity but an inappropriate amount of time is spent discussing some of the cases
Patient cases are discussed in a clear order but time is used inappropriately in some cases
Patient cases are discussed in a clear order and an appropriate amount of time is spent discussing each case
  
(1)
(2)
(3)
(4)
Organisation/admin during meetings:
      
a) patient notes
Availability of patient notes
No patient records available at meeting
Some required past/current reports not available
Hardcopy and all necessary past/current reports available
Electronic access to patient notes and all necessary past/current reports available
  
(1)
(2)
(3)
(4)
b) case presentation
Comprehensiveness and coherence of case presentation
Rambling; entirely reading from notes; does not seem familiar with patient
Some evidence of familiarity with patient and info presented in reasonable fashion
Comprehensive succinct coherent presentation (evidence of familiarity with patient and findings)
  
(1)
(2)
(3)
Clinical decision making
    
Patient centred care
Includes mention of patient-based information (e.g. demography; co-morbidities; psycho-social or supportive needs; patient wishes/family preferences)
Patient-centred factors sufficiently acknowledged in less than 20% cases
Patient-centred factors sufficiently acknowledged in less than 50% cases
Patient-centred factors sufficiently acknowledged in 50% + cases (but not all cases)
Patient-centred factors sufficiently acknowledged in all cases
  
(1)
(2)
(3)
(4)
Treatment plans
Clarity of treatment plan
Treatment plan not discernable
Treatment plan communicated verbally
Treatment plan communicated verbally and recorded
Treatment plan communicated verbally, recorded with a clearly articulated plan regarding the next steps.
  
(1)
(2)
(3)
(4)
Characteristic of Effective MDT-working
Quality Criteria
Quality of team-working (score in brackets)
Teamworking & culture
 
severe and sustained conflict
overt conflict un-sustained
tension sustained
tension un-sustained
no tension
  
(−4)
(−3)
(−2)
(−1)
(0)
d) tension/conflict
Extent of tension and/or conflict observable in the team
≥1clear example of conflict observed which persists throughout meeting
≥1clear example of conflict observed does not persist throughout meeting
≥1 instance of tension observed which persists throughout meeting
≥1 instance of tension observed but does not persist throughout meeting
No tension
Quality criteria for each characteristic were initially informed by relevant literature, observation of MDMs in a range of tumour types, and review of the survey data that had informed the Characteristics [18]. These prototype quality criteria were subsequently reviewed by an independent panel consisting of a consultant radiologist, oncologist and nurse with bowel cancer expertise as well as a senior NHS cancer manager. The panel discussed the potential variation in quality for each characteristic. Optimal ratings were calibrated against the recommendations in the Characteristics. Thresholds for lower quality performance were based on consensual agreement about the added value or detriment to MDT-working of variations to the optimal rating. It was agreed that the variation in quality for most characteristics would best be represented on a four-point scale: very poor (1), poor (2), good (3) or very good (4). Very poor/poor were merged for three characteristics where it was felt that further categorisation would lose value (Table 1).
Video-taped observation was proposed for rating behavioural characteristics such as chairing, teamwork and decision-making, to enable multiple observers to rate identical footage and allow replay. To enhance the reliability of behavioural ratings a case discussion proforma was deve-loped for rating characteristics on a case-by-case basis prior to being aggregated to an overall rating (Additional file 1). Aggregation was a qualitative process for most characteristics: forming global judgments on the rating that best reflected performance based on notes taken for individual cases. The only exception was patient centred care where the rating was based on quantification of objective content. This was because it would be necessary to know the patient in order to value-judge this characteristic of effectiveness. Rating is instead based on the frequency that patient-based information is considered (Table 1). Aspects of team functioning that could not easily be observed on a video-taped recording and could be objectively described were rated on the basis of notes and/or information collected by the researcher at the time of the videotaped meeting. This included attendance, the meeting agenda, meeting venue and technology. The researcher who was present at the meeting verified attendance information from the MDT lead and/or MDT coordinator, obtained an anonymised hard copy of the meeting agenda, and recorded information about the meeting venue and technology on a study-specific proforma (Additional file 2) to ensure systematic recording of the detail required for assessing these criteria.

Piloting MDT-OARS: acceptability and variation in performance

Ten bowel cancer teams volunteered to participate (ascertained via their participation in another study [20]). One MDM per team was filmed and observed in-vivo. Quality was subsequently assessed using completed case discussion proformas, the completed in-vivo proforma and anonymised agenda (Table 1, Additional files 1 and 2). Short structured interviews were conducted with a range of members from each team (including at minimum the MDT lead, MDT coordinator and clinical nurse specialist) to determine the impact of the observational method on the meeting, and confirm attendance information.
Team members provided written informed consent prior to the meeting being video-recorded and all patient discussions and agendas were anonymised. Ethics approval was granted by the South East Multi-Centre Research Ethics Committee and R & D approval was obtained from the relevant NHS Trust for each MDT.

Analysis

Quality ratings for each characteristic are presented in their unstandardized form and are summed to provide an overall score out of 58 (Table 2). The ratings for all characteristics except teamworking: presence of tension/conflict were standardised to the same scale and either presented on a scale of 1–4 or dichotomised (very poor/poor vs. good/very good) to enable visual comparison of variability in quality within and between teams. Rating of the presence of tension/conflict is not presented graphically as the scale was not compatible.
Table 2
Quality of teamworking in 10 bowel cancer teams: unstandardized scores
Characteristic of effective teamworking
Rating scale
Team
Total number of teams ‘very good’
1
2
3
4
5
6
7
8
9
10
Score (see Table 1 for criteria)
The Team
Attendance
1 to 4
4
4
3
1
2
2
4
4
4
4
6
Leadership: chairing of meeting
1 to 4
2
4
1
3
2
2
3
3
3
2
1
Teamworking & culture:
            
a)Inclusion of relevant team members
1 to 4
2
2
2
4
2
3
3
2
4
4
3
b) Team Sociability
1 to 4
1
3
2
4
3
2
3
1
4
2
2
c) Mutual respect
1 to 4
2
4
2
4
2
2
3
2
4
4
4
d) tension and conflict
0 to −4
0
0
−1
0
0
−1
0
−1
0
−1
6
Personal development & training
1 to 3
1
3
2
2
2
1
1
2
2
2
1
Infrastructure for meetings
 
Meeting venue
1 to 4
2
3
3
1
2
3
4
3
4
3
2
Technology & equipment
2 to 9
7
9
5
3
3
7
7
6
9
7
2
Meeting organisation and logistics
 
Preparation prior to meetings:
            
a) agenda
1 to 3
3
3
2
3
2
3
3
3
3
2
7
b) Prioritisation of complex cases
1 to 4
1
2
1
1
2
2
2
2
2
1
0
Organisation/admin in MDM a) patient notes
1 to 4
3
3
2
2
2
3
3
3
3
3
0
b) Case presentation
1 to 3
2
3
1
3
2
2
2
2
3
2
3
Clinical decision making
 
Patient-centred care
1 to 4
1
3
2
2
3
2
2
1
2
2
0
Treatment plans
1 to 4
2
4
2
4
1
3
1
2
3
3
2
Total rating
11-58
33
50
29
37
30
36
41
35
50
40
 

Feasibility and inter-rater reliability

Feasibility was estimated by collecting data on the time taken to complete observational assessments. Inter-rater reliability was assessed by comparing the ratings of the research team with those of two independent observers: one oncology specialist registrar and one post-doctoral research psychologist. Intraclass correlation coefficients were calculated (two-way mixed models with measures of absolute agreement). 95% confidence intervals are shown. A significance level of p = 0.05 was used. Data were analysed using SPSS v.15.0 for windows.

Results

Criteria for assessing MDM quality

The quality criteria and methods for assessing each characteristic are summarized in Table 1.

Acceptability and team meeting characteristics

Presence of an observer and videocamera in MDT meetings was acceptable to team members and feasible to implement: it caused no delay or interruption to the usual flow of meetings. Interviews with team members confirmed all meetings had been typical: the presence of the researcher and camera had negligible impact on team member behaviour.
Meetings ranged in size from having 10 to 45 core and extended members present (median 16 members). The largest MDT meeting was a network-wide meeting comprising three local MDTs; all others comprised one local MDT. The average meeting length was 53minutes (range: 25–86 minutes) and teams discussed an average of 13 patients (range: 6–21 patients). Each patient was discussed for an average of 4.5 minutes (range 3–9 minutes).

Variation in team performance between teams

There was wide diversity in ratings between teams across all characteristics. Total scores (out of a possible 59) ranged from 29 (team 3) to 50 (teams 2 and 9; Table 2). Only one team (Team 3) failed to achieve ‘very good’ criteria for at least one characteristic. The quality of teamwork in this team was particularly poor in relation to chairing (the chair allowed long pauses in discussions and did not explicitly confirm treatment plans before moving onto the next case); prioritisation of the agenda (9/14 cases discussed were rated as having too much time spent on them as key information or results were missing, or because relevant team members, for example the oncologist, were absent); and presentation of clinical information (case presentations were unprepared and unstructured, time was spent searching for relevant information for most cases). In contrast, Teams 2 and 9 met ‘very good’ criteria for 9 out of the 15 characteristics. These teams demonstrated: optimal chairing (by ensuring discussions remained focused and clearly articulating treatment plans); inclusion of all relevant team members in discussions (most other teams, although not always dominated by one or two members, particularly lacked contribution from the clinical nurse specialist or any other nurses); explicit use of the meeting for professional development (a well prepared, informative discussion about a waiting times breach resulting in clear actions); optimal venue and technology (a spacious purpose-built room; core team seated in horseshoe formation enabling sight of imaging/pathology and each other. Picture Archiving and Communications System (PACS) and multiple screens facilitated viewing of current and retrospective pathology and radiological imaging); circulation of a comprehensive agenda prior to meetings (including patient ID and demographics, all previous relevant history, tests undertaken/results, reason for MDT discussion, and space for MDT recommendation to be inserted).

Variation in team performance within teams

Some internal consistency within teams was evident: MDTs performing well in one domain tended to perform well in other domains (and vice versa, Figure 1). Eight out of the 10 teams had the same rating (either ‘very good/good’ or ‘very poor/poor’) for at least three of the four domains of teamworking. The internal consistency was most evident in teams performing at either end of the spectrum: Team 3 received consistently poor ratings across all characteristics with three ‘very poor’ ratings and no ‘very good’ ratings, and teams 2 and 9 received 9 ‘very good’ ratings and had no ‘very poor’ ratings of quality for any characteristic (Table 2).

Characteristics of effectiveness most and least likely to be achieved

Teams were most likely to achieve ‘very good’ ratings for: administrative preparation (a comprehensive agenda), membership/attendance (all core team members or deputies present for whole meeting), and tension/conflict (no tension or conflict in meetings) (Table 2, Figure 2). Teams were least likely to achieve ‘very good’ ratings for: patient-centredness of case discussions and prioritisation of cases on the agenda. No teams were observed to explicitly consider patient-centred factors in all patient discussions: most teams considered patient-based factors in less than half of cases, mostly comprising demographic information rather than holistic needs or preferences. There was no attempt by any team to use the agenda to prioritise the order of case discussions to ensure appropriate time was spent discussing complex cases. In all teams at least some cases were judged as being discussed for too little or too much time based on their complexity.

Feasibility and inter-rater reliability

Completion of assessments required 93 minutes on average (range: 45–160 minutes). There was no consistent difference in time taken by different observers; instead the time taken was associated with meeting length, averaging between 1.25 and 2 times the meeting length. There was a trend for assessments to take longer initially (average 2 times length of meeting) compared to the final few teams observed (average 1.25 times length of meeting).
Acceptable intra-class correlation coefficients of at least 0.50 (and up to 0.92) were achieved for all except two characteristics of effective teamworking: the absence of tension/conflict (ICC = 0.10) and evidence of treatment planning (ICC = 0.32; Table 3).
Table 3
Inter-rater reliability of ratings across three independent observers
Rating Scale domains
Intraclass correlation coefficient (95% confidence interval)
Significance (p)
THE TEAM
  
Attendance
n/a – rating based on in-vivo factual information
 
Leadership: chairing of the meeting
0.58 (−0.37 to 0.90)
0.07
Teamworking & culture:
  
a) Inclusion of all relevant team members
0.68 (0.07 to 0.92)
0.02
b) Team sociability
0.52 (−0.56 to 0.89)
0.10
c) Mutual respect between participants
0.72 (0.21 to 0.93)
0.01
d) Tension/conflict
0.10 (−0.92 to 0.73)
0.40
Personal development and training
0.74 (0.23 to 0.93)
0.01
INFRASTRUCTURE FOR MEETINGS
  
Meeting venue
0.92 (0.76 to 0.98)
<0.001
Technology & equipment
0.92 (0.76 to 0.98)
<0.001
MEETING ORGANISATION AND LOGISTICS
  
Preparation prior to meetings:
a) agenda
0.55 (−0.13 to 0.87)
0.04
b) prioritisation of complex cases
n/a rated by one observer only
 
Organisation/admin during meetings:
a) patient notes
0.47 (−0.27 to 0.85)
0.07
b) case presentation
0.74 (0.16 to 0.94)
0.01
CLINICAL DECISION-MAKING PROCESS
  
Patient-centred care
0.77 (0.24 to 0.95)
0.01
Treatment Plan
0.32 (−0.84 to 0.83)
0.23

Discussion

We have developed a novel, observational measure for assessing quality in cancer MDT meetings. The quality criteria are calibrated against ‘effectiveness’ as defined by consensus from over 2000 MDT members, and measure quality in relation to 15 aspects of observable activity in MDT meetings. Our preliminary study has shown that independent observation of MDT meetings is acceptable to teams and feasible to conduct. Whilst only a small number of teams participated in this pilot study, the application of the measure highlighted wide diversity in the quality of teamworking across the range of characteristics measured.
Teams typically performed well in terms of the administrative preparation for meetings and having the appropriate team members in attendance. They performed less well in relation to spending adequate time discussing cases (requiring case prioritisation on the agenda), and having patient-centred case discussions. Both of these aspects of MDT function require additional preparation time, either in relation to compiling and assessing case information to determine their complexity, and/or additional time with patients to comprehensively assess their history, needs and wishes. The importance of undertaking regular assessment of patients' needs and preferences (now referred to as holistic needs assessment [21]) was highlighted in the NICE guidance for improving supportive and palliative care [22] and generally it is expected Clinical Nurse Specialists (CNS) should lead this. Ensuring patient-led decision making is fostered in the MDT meetings, where patients are not present, is challenging due to the time pressures of meetings and requires further attention. Nevertheless if the opportunity is not grasped for information to be obtained and shared with the wider team at the earliest opportunity it may fail to impact on decision making, or may cause avoidable delays to treatment [9, 10]. In this study, few nurses contributed to case discussions which may at least in part explain the lack of patient-based information discussed. Similar findings have been reported elsewhere [23]. Although responsibility for ensuring that recommendations are patient-centred rests with the whole team, training and support to enhance nurses’ involvement in MDT discussions may be warranted.
This pilot study was aimed at determining ‘proof of concept’ and has demonstrated that it is acceptable and feasible to measure complex aspects of team behaviour and activities such as leadership, teamworking and decision-making. The calibration of quality criteria against characteristics of effectiveness agreed by a large sample of MDT members, in addition to using available evidence and expert input, ensured content validity. Furthermore, most characteristics were measured reliably in the hands of different observers. There was low agreement in ratings for the presence of tension/conflict and the clarity of treatment recommendations which may be related to level of clinical experience. The quality criteria require refinement to increase their reliability or it may be necessary for observers to have relevant clinical experience for the ratings of these aspects of teamworking to be valid.
Further testing is required with more teams and other tumour types. Only one meeting was assessed per team which may not have adequately represented their teamworking. Team members confirmed that the filmed meetings were typical of their usual meetings in all cases, but some aspects of teamworking may have been more reliably rated longitudinally. This may be particularly important where behaviour or performance receives a poor rating. Furthermore, the teams volunteered through their participation in another study. It is necessary to test this method of observational assessment with other teams to further confirm its acceptability. Validation of ratings against other subjective and objective outcomes (such as team member assessments of their own performance, clinical outcomes, peer review data & national patient experience data) will be important to further define the characteristics of effective teamworking. The current design of the tool, based upon rating case-by-case, enhanced objectivity of ratings but was time consuming and is likely to require simplification to have clinical as well as research utility. Together with further validation, it may be desirable to develop quality criteria for other characteristics of MDM effectiveness. In particular this could include other aspects of case discussions such as presentation of nationally agreed minimum datasets for radiology, pathology and clinical data; and adherence to relevant nationally and locally agreed protocols. Such assessment may require observers with clinical expertise, at least for assessment of these aspects of team functioning.
The variation in quality of teamworking we report reinforces the need to provide teams with appropriate assessment tools, resources and training to optimise their performance. Indeed 85% of MDT members that responded to the UK national survey agreed MDTs need performance measures [18].

Conclusion

The preliminary testing of MDT-OARS indicates this could be a useful component of MDT assessment, alongside other measures of the quality of patient care provided by MDTs including peer review and patient experience surveys.

Misc

This study was funded by Cancer Research UK and by the COMPASS Collaborative, a National Cancer Research Institute Supportive and Palliative Care Research Collaborative.

Role of funding source

The funding bodies had no role in the study design; collection, analysis, interpretation of data; writing the report; or the decision to submit for publication.

Acknowledgements

This study was funded by Cancer Research UK and by the COMPASS Collaborative, a National Cancer Research Institute Supportive and Palliative Care Research Collaborative.
We thank the bowel cancer teams for participating in this study; Dr Gina Brown, Dr Nick Maisey, Dr Claire Taylor and Teresa Moss for their contributions to the development of quality criteria; and Emma Teasdale, Liz Jamieson, Jo Sippitt, and Claire Nollett for their assistance with data collection and analysis.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interest

The authors declare they have no competing interests.

Authors' contributions

All named authors have agreed to the submission of this manuscript and participated in this study to a sufficient extent to be named as authors. AJR, AR and CT conceived the idea for the study; CT was the study lead and wrote the first draft of the paper. All authors participated in the development and/or application of the quality criteria, the critical revision of the article and have read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Taylor C, Munro AJ, Glynne-Jones R, Griffiths C, Trevatt P, Richards MA, Ramirez AJ: Multidisciplinary team working in cancer: where are we now?. British Medical Journal BMJ. 2010, 340: c951-10.1136/bmj.c951.CrossRefPubMed Taylor C, Munro AJ, Glynne-Jones R, Griffiths C, Trevatt P, Richards MA, Ramirez AJ: Multidisciplinary team working in cancer: where are we now?. British Medical Journal BMJ. 2010, 340: c951-10.1136/bmj.c951.CrossRefPubMed
2.
Zurück zum Zitat Lamb B, Brown K, Nagpal K, Vincent C, Green JSA, Sevdalis N: Team decision making by cancer care multidisciplinary teams: a systematic review. Ann Surg Oncol. 2011, 18 (8): 2116-2125. 10.1245/s10434-011-1675-6.CrossRefPubMed Lamb B, Brown K, Nagpal K, Vincent C, Green JSA, Sevdalis N: Team decision making by cancer care multidisciplinary teams: a systematic review. Ann Surg Oncol. 2011, 18 (8): 2116-2125. 10.1245/s10434-011-1675-6.CrossRefPubMed
3.
Zurück zum Zitat Department of Health: The Manual for Cancer Services. 2004, Department of Health, London Department of Health: The Manual for Cancer Services. 2004, Department of Health, London
4.
Zurück zum Zitat National Cancer Action Team: National Cancer Peer Review Programme 2004–2007. National Report: An Overview of the Findings from the Second National Round of Peer Reviews of Cancer Services in England. 2008, National Cancer Action Team, London National Cancer Action Team: National Cancer Peer Review Programme 2004–2007. National Report: An Overview of the Findings from the Second National Round of Peer Reviews of Cancer Services in England. 2008, National Cancer Action Team, London
5.
Zurück zum Zitat Davies AR, Deans DA, Penman I, Plevris JN, Fletcher J, Wall L, Phillips H, Gilmour H, Patel D, de Beaux A, Paterson-Brown S: The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus. 2006, 19 (6): 496-503. 10.1111/j.1442-2050.2006.00629.x.CrossRefPubMed Davies AR, Deans DA, Penman I, Plevris JN, Fletcher J, Wall L, Phillips H, Gilmour H, Patel D, de Beaux A, Paterson-Brown S: The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus. 2006, 19 (6): 496-503. 10.1111/j.1442-2050.2006.00629.x.CrossRefPubMed
6.
Zurück zum Zitat Coory M, Gkolia P, Yang I, Bowman R, Fong K: Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008, 60: 14-21. 10.1016/j.lungcan.2008.01.008.CrossRefPubMed Coory M, Gkolia P, Yang I, Bowman R, Fong K: Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008, 60: 14-21. 10.1016/j.lungcan.2008.01.008.CrossRefPubMed
7.
Zurück zum Zitat Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D: MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer. 2006, 94 (3): 351-357. 10.1038/sj.bjc.6602947.CrossRefPubMedPubMedCentral Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D: MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer. 2006, 94 (3): 351-357. 10.1038/sj.bjc.6602947.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Leo F, Venissac N, Poudenx M, Otto J: Mourox Jand the Groupe d'Oncologie Thoracique Azureen (GOThA): Multidisciplinary management of lung cancer: how to test its efficacy?. J Thorac Oncol. 2007, 2 (1): 69-72. 10.1097/JTO.0b013e31802bff56.CrossRefPubMed Leo F, Venissac N, Poudenx M, Otto J: Mourox Jand the Groupe d'Oncologie Thoracique Azureen (GOThA): Multidisciplinary management of lung cancer: how to test its efficacy?. J Thorac Oncol. 2007, 2 (1): 69-72. 10.1097/JTO.0b013e31802bff56.CrossRefPubMed
9.
Zurück zum Zitat Stalfors J, Lundberg C, Westin T: Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer. Acta Otolaryngol (Stockh). 2007, 127 (1): 82-87. 10.1080/00016480600740589.CrossRef Stalfors J, Lundberg C, Westin T: Quality assessment of a multidisciplinary tumour meeting for patients with head and neck cancer. Acta Otolaryngol (Stockh). 2007, 127 (1): 82-87. 10.1080/00016480600740589.CrossRef
10.
Zurück zum Zitat Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL: Analysis of clinical decision-making in multidisciplinary cancer teams. Ann Oncol. 2006, 17 (3): 457-460. 10.1093/annonc/mdj102.CrossRefPubMed Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL: Analysis of clinical decision-making in multidisciplinary cancer teams. Ann Oncol. 2006, 17 (3): 457-460. 10.1093/annonc/mdj102.CrossRefPubMed
11.
Zurück zum Zitat Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS: Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011, 35 (9): 1970-1976. 10.1007/s00268-011-1152-1.CrossRefPubMed Lamb BW, Sevdalis N, Arora S, Pinto A, Vincent C, Green JS: Teamwork and team decision-making at multidisciplinary cancer conferences: barriers, facilitators, and opportunities for improvement. World J Surg. 2011, 35 (9): 1970-1976. 10.1007/s00268-011-1152-1.CrossRefPubMed
12.
Zurück zum Zitat Lanceley AS, Savage J, Menon U, Jacobs I: Influences on multidisciplinary team decision-making. Int J Gynecol Cancer. 2008, 18 (2): 215-222. 10.1111/j.1525-1438.2007.00991.x.CrossRefPubMed Lanceley AS, Savage J, Menon U, Jacobs I: Influences on multidisciplinary team decision-making. Int J Gynecol Cancer. 2008, 18 (2): 215-222. 10.1111/j.1525-1438.2007.00991.x.CrossRefPubMed
13.
Zurück zum Zitat Kidger J, Murdoch J, Donovan JL, Blazeby JM: Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJOG. 2009, 116 (4): 511-517. 10.1111/j.1471-0528.2008.02066.x.CrossRefPubMed Kidger J, Murdoch J, Donovan JL, Blazeby JM: Clinical decision-making in a multidisciplinary gynaecological cancer team: a qualitative study. BJOG. 2009, 116 (4): 511-517. 10.1111/j.1471-0528.2008.02066.x.CrossRefPubMed
14.
Zurück zum Zitat Carthey: The role of structured observational research in healthcare. Qual Saf Health Care. 2003, 12 (Suppl II): ii13-ii16.PubMedPubMedCentral Carthey: The role of structured observational research in healthcare. Qual Saf Health Care. 2003, 12 (Suppl II): ii13-ii16.PubMedPubMedCentral
15.
Zurück zum Zitat Bower P, Campbell S, Bojke C, Sibbald B: Team structure, team climate and the quality of care in primary care: an observational study. Qual Saf Health Care. 2003, 12: 273-279. 10.1136/qhc.12.4.273.CrossRefPubMedPubMedCentral Bower P, Campbell S, Bojke C, Sibbald B: Team structure, team climate and the quality of care in primary care: an observational study. Qual Saf Health Care. 2003, 12: 273-279. 10.1136/qhc.12.4.273.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Undre S, Sevdalis N, Vincent C: Observing and assessing surgical teams: The Observational Teamwork Assessment for Surgery©(OTAS)©. Safer surgery: analysing behaviour in the operating theatre. Ashgate. Edited by: Flin R, Mitchell L. 2009 Undre S, Sevdalis N, Vincent C: Observing and assessing surgical teams: The Observational Teamwork Assessment for Surgery©(OTAS)©. Safer surgery: analysing behaviour in the operating theatre. Ashgate. Edited by: Flin R, Mitchell L. 2009
17.
Zurück zum Zitat Healey A, Undre S, Vincent C: Developing observational measures of performance in surgical teams. Qual Saf Health Care. 2004, 13 (Suppl 1): i33-i40.CrossRefPubMedPubMedCentral Healey A, Undre S, Vincent C: Developing observational measures of performance in surgical teams. Qual Saf Health Care. 2004, 13 (Suppl 1): i33-i40.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Taylor C, Ramirez AJ: Multidisciplinary team members' views about MDT working: results from a survey commissioned by the National Cancer Action Team. 2009, National Cancer Action Team, , Available at: www.ncin.org.uk/mdt Taylor C, Ramirez AJ: Multidisciplinary team members' views about MDT working: results from a survey commissioned by the National Cancer Action Team. 2009, National Cancer Action Team, , Available at: www.ncin.org.uk/mdt
20.
Zurück zum Zitat Taylor C, Sippitt J, Collins G, McManus C, Richardson A, Dawson J, Richards M, Ramirez A: A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members. BMC Health Serv Res. 2010, 10: 187-10.1186/1472-6963-10-187.CrossRefPubMedPubMedCentral Taylor C, Sippitt J, Collins G, McManus C, Richardson A, Dawson J, Richards M, Ramirez A: A pre-post test evaluation of the impact of the PELICAN MDT-TME Development Programme on the working lives of colorectal cancer team members. BMC Health Serv Res. 2010, 10: 187-10.1186/1472-6963-10-187.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat National Institute for Clinical Excellence: Guidance on cancer services: improving supportive and palliative care for adults with cancer. 2004, NICE, London National Institute for Clinical Excellence: Guidance on cancer services: improving supportive and palliative care for adults with cancer. 2004, NICE, London
23.
Zurück zum Zitat Lamb BW, Wong HWL, Vincent C, Green JSA, Sevdalis N: Teamwork and team performance in multidisciplinary cancer teams: development and evaluation of an observational tool. BMJ Qual Saf. 2011, 20 (10): 849-856. 10.1136/bmjqs.2010.048660.CrossRefPubMed Lamb BW, Wong HWL, Vincent C, Green JSA, Sevdalis N: Teamwork and team performance in multidisciplinary cancer teams: development and evaluation of an observational tool. BMJ Qual Saf. 2011, 20 (10): 849-856. 10.1136/bmjqs.2010.048660.CrossRefPubMed
Metadaten
Titel
Measuring the quality of MDT working: an observational approach
verfasst von
Cath Taylor
Louise Atkins
Alison Richardson
Ruth Tarrant
Amanda-Jane Ramirez
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2012
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-202

Weitere Artikel der Ausgabe 1/2012

BMC Cancer 1/2012 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.